UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dendritic spine density is altered in a mouse model of Cockayne syndrome

Neuropathology and applied neurobiology, 2013-06, Vol.39 (4), p.437-440

2013

Volltextzugriff (PDF)

The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration

Current drug targets. CNS & neurological disorders, 2002-08, Vol.1 (4), p.399-411

2002

Volltextzugriff (PDF)

Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease

Neuropharmacology, 2019-03, Vol.147, p.11-27

2019

Volltextzugriff (PDF)

Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice

Human molecular genetics, 2008-05, Vol.17 (10), p.1386-1396

2008

Volltextzugriff (PDF)

Nicotine, but neither the α4β2 ligand RJR2403 nor an α7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle

Neuropharmacology, 2006-09, Vol.51 (3), p.506-516

2006

Volltextzugriff (PDF)

Dendritic spine density is altered in a mouse model of C ockayne syndrome

Neuropathology and applied neurobiology, 2013-06, Vol.39 (4), p.437-440

2013

Volltextzugriff (PDF)

Deep brain stimulation of the subthalamic nucleus preferentially alters the translational profile of striatopallidal neurons in an animal model of Parkinson's disease

Frontiers in cellular neuroscience, 2015-06, Vol.9, p.221-221

2015

Volltextzugriff (PDF)

Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and α6 and β3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat

Neuropharmacology, 2006-01, Vol.50 (1), p.36-46

2006

Volltextzugriff (PDF)

α 1 -Adrenoceptors Mediate Dihydroxyphenylalanine-Induced Activity in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaques

The Journal of pharmacology and experimental therapeutics, 2009-01, Vol.328 (1), p.276-283

2009

Volltextzugriff (PDF)

The nociceptin/orphanin FQ (NOP) receptor antagonist J-113397 enhances the effects of levodopa in the MPTP-lesioned nonhuman primate model of Parkinson's disease

Movement disorders, 2008-10, Vol.23 (13), p.1922-1925

2008

Volltextzugriff (PDF)

Nicotine, but neither the alpha 4 beta 2 ligand RJR2403 nor an alpha 7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle

Neuropharmacology, 2006-09, Vol.51 (3), p.506-516

2006

Volltextzugriff (PDF)

Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle

Neuropharmacology, 2006-09, Vol.51 (3), p.506

2006

Volltextzugriff (PDF)

Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat

Neuropharmacology, 2006-01, Vol.50 (1), p.36-46

2006

Volltextzugriff (PDF)

Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha sub(6) and beta sub(3) nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat

Neuropharmacology, 2006-01, Vol.50 (1), p.36-46

2006

Volltextzugriff (PDF)

Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease

Archives of neurology (Chicago), 2006-09, Vol.63 (9), p.1343

2006

Volltextzugriff (PDF)

Alpha1-adrenoceptors mediate dihydroxyphenylalanine-induced activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaques

The Journal of pharmacology and experimental therapeutics, 2009-01, Vol.328 (1), p.276

2009

Volltextzugriff (PDF)

Neuronal Nicotinic Receptors and Neuroprotection: Newer Ligands May Help us Understand their Role in Neurodegeneration

Medicinal Chemistry Reviews - Online, 2005-12, Vol.2 (6), p.455-471

2005

Volltextzugriff (PDF)

An AI-guided screen identifies probucol as an enhancer of mitophagy through modulation of lipid droplets

PLoS biology, 2023-03, Vol.21 (3), p.e3001977

2023

Volltextzugriff (PDF)

Retraction Note to: Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors

BMC neuroscience, 2021-06, Vol.22 (1), p.1-40, Article 40

2021

Volltextzugriff (PDF)

An AI-guided screen identifies probucol as an enhancer of mitophagy through modulation of lipid droplets

PLoS biology, 2023-03, Vol.21 (3)

2023

Volltextzugriff (PDF)

Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease

Annals of neurology, 2021-07, Vol.90 (1), p.76-88

2021

Volltextzugriff (PDF)

Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson's disease

Canadian journal of neurological sciences, 2010-01, Vol.37 (1), p.86-95

2010

Volltextzugriff (PDF)

Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors

BMC neuroscience, 2008-09, Vol.9 (1), p.92-92

2008

Volltextzugriff (PDF)

Actions at sites other than D3 receptors mediate the effects of BP897 on L-DOPA-induced hyperactivity in monoamine-depleted rats

Experimental neurology, 2006-11, Vol.202 (1), p.85-92

2006

Volltextzugriff (PDF)

RETRACTED ARTICLE: Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors

BMC neuroscience, 2008-09, Vol.9 (1), Article 92

2008

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(28)
Webseiten
(1)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Animals
(11)
Neurosciences & Neurology
(9)
Parkinson's Disease
(7)
Biological And Medical Sciences
(6)
Neurosciences
(6)
Clinical Neurology
(5)
Disease Models, Animal
(4)
Humans
(4)
Male
(4)
Biochemistry & Molecular Biology
(3)
Callithrix
(3)
Dopamine
(3)
Female
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Life Sciences
(3)
Medical Sciences
(3)
Mice
(3)
Mice, Knockout
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dendritic spine density is altered in a mouse model of Cockayne syndrome

The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration

Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease

Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice

Nicotine, but neither the α4β2 ligand RJR2403 nor an α7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle

Dendritic spine density is altered in a mouse model of C ockayne syndrome

Deep brain stimulation of the subthalamic nucleus preferentially alters the translational profile of striatopallidal neurons in an animal model of Parkinson's disease

Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and α6 and β3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat

α 1 -Adrenoceptors Mediate Dihydroxyphenylalanine-Induced Activity in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaques

The nociceptin/orphanin FQ (NOP) receptor antagonist J-113397 enhances the effects of levodopa in the MPTP-lesioned nonhuman primate model of Parkinson's disease

Nicotine, but neither the alpha 4 beta 2 ligand RJR2403 nor an alpha 7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle

Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle

Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat

Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha sub(6) and beta sub(3) nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat

Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease

Alpha1-adrenoceptors mediate dihydroxyphenylalanine-induced activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaques

Neuronal Nicotinic Receptors and Neuroprotection: Newer Ligands May Help us Understand their Role in Neurodegeneration

An AI-guided screen identifies probucol as an enhancer of mitophagy through modulation of lipid droplets

Retraction Note to: Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors

An AI-guided screen identifies probucol as an enhancer of mitophagy through modulation of lipid droplets

Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease

Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson's disease

Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors

Actions at sites other than D3 receptors mediate the effects of BP897 on L-DOPA-induced hyperactivity in monoamine-depleted rats

RETRACTED ARTICLE: Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors

Suchergebnisse filtern